Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Criteria for inclusion of confirmed patients: (1) Comply with the diagnostic criteria of "Pneumonitis Diagnosis and Treatment Scheme for Novel Coronavirus Pneumonia (COVID-19) (Trial Version 5)"; (2) Above 2 years old; 2. Inclusion criteria for close contacts: One of the following contact situations after the onset of the case, but did not take effective protection: (1) People who live, study, work or have close contact with the case, such as working close to the case or sharing the same classroom or living in the same house as the case; (2) Medical staff, family members, or other people who have close contact with the case, such as direct treatment and care of the case, visiting or staying in the closed environment where the case is located, and the case is the same as other cases in the ward. Patients and their caregivers; (3) People who are in the same transportation as the case and have close contact with them, including those who have taken care of the patient on the transportation, and the patient's colleagues (family, colleagues, friends, etc.) are found to be likely to be near Distance from other passengers and flight attendants who are in contact with the patient; (4) On-site investigators evaluate that they are qualified to meet other contacts with close contacts.
Exclusion criteria
Exclusion criteria: (1) Patients during pregnancy; (2) Complicated liver, kidney, and metabolic diseases; (3) Have other serious primary cardiovascular disease, kidney disease, liver disease, hematological changes, or serious diseases that affect its quality of life, such as malignant tumors, AIDS, etc.; (4) Have or suspect a history of alcohol, drug abuse, etc.; (5) People with mental illness or manic disorder, or unwilling to accept research measures, or unwilling to cooperate with others; (6) Those who have participated in other clinical studies and influenced the results of this survey.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| disease incidence;Duration of PCR normalization;Distribution pattern of TCM syndromes; | — |
Secondary
| Measure | Time frame |
|---|---|
| Chest imaging;incidence of complication;quality of life;Hospitalization time;Clinical symptom score; | — |
Countries
China
Contacts
Affiliated Hospital of Shandong University of Traditional Chinese Medicine